Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Focal Epilepsy With and Without Secondary Generalization”

10 trials

Showing 10 of 10 results

Post-approval studies (Phase 4)Ended earlyNCT00165828
What this trial is testing

Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization

Who this might be right for
Epilepsy
Eisai GmbH 157
Not applicableLooking for participantsNCT06716801
What this trial is testing

Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain

Who this might be right for
Focal Epilepsy With and Without Secondary Generalization
Aziende Chimiche Riunite Angelini Francesco S.p.A 300
Testing effectiveness (Phase 2)Ended earlyNCT04529954
What this trial is testing

Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion

Who this might be right for
Focal Epilepsy
Cerebral Therapeutics LLC 20
Not applicableLooking for participantsNCT06792383
What this trial is testing

Psychological and Psychiatric Assessment in Patients Eligible for Epilepsy Surgery

Who this might be right for
Focal Epilepsy With and Without Secondary Generalization
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 180
Large-scale testing (Phase 3)Study completedNCT01392768
What this trial is testing

Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization

Who this might be right for
EpilepsyPartial Seizures
Ache Laboratorios Farmaceuticos S.A. 126
Testing effectiveness (Phase 2)Study completedNCT00210652
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

Who this might be right for
EpilepsyEpilepsies, Partial
SK Life Science, Inc. 47
Testing effectiveness (Phase 2)Ended earlyNCT04153175
What this trial is testing

Study to Assess Intracerebroventricular (ICV) Delivery of CT-010 in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization

Who this might be right for
Refractory Epilepsy
Cerebral Therapeutics LLC 30
Large-scale testing (Phase 3)Study completedNCT02124564
What this trial is testing

A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures

Who this might be right for
EpilepsyPartial-onset Seizures
UCB Japan Co. Ltd. 19
Not applicableStudy completedNCT03082222
What this trial is testing

ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions

Who this might be right for
Focal Epilepsy
Eisai GmbH 246
Not applicableStudy completedNCT01673282
What this trial is testing

Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy

Who this might be right for
Focal Epilepsy With and Without Secondary Generalization
UCB Pharma GmbH 315

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation